Geoffrey M. Parker
CIK 1491874 · CHIEF FINANCIAL OFFICER · last filed 2026-05-15
Geoffrey M. Parker is a CHIEF FINANCIAL OFFICER who has filed 126 SEC Form 4 insider transactions across 9 companies since 2010. The most recent filing, for PRGO, was dated May 15, 2026. Across all open-market trades the lifetime net is +$5.8M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $3.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.02M
9
126
$5.82M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PRGO | Director | 58,589 | $10.99 | $643.9K | $1.63M | 31 | 2026-05-15 |
| ALLO | CHIEF FINANCIAL OFFICER | 1,252,795 | $1.90 | $2.38M | -$95.3K | 9 | 2026-02-04 |
| Better Therapeutics, Inc. (BTTX) Delisted | Director | 1,085,138 | $0.04 | $48.4K | $917.2K | 9 | 2023-12-20 |
| CCXI | Director | 0 | $10.22 | $0 | -$2.61M | 25 | 2022-10-24 |
| Tricida, Inc. (TCDA) Delisted | COO, CFO and EVP | 118,617 | $0.11 | $12.8K | $4.25M | 17 | 2022-03-02 |
| GENOMIC HEALTH INC (GHDX) Delisted | Director | 955 | — | — | $0 | 4 | 2019-06-18 |
| Viracta Therapeutics, Inc. (SNSS) Delisted | Director | 13,480 | $18.62 | $251.0K | $58.2K | 6 | 2017-06-02 |
| Anacor Pharmaceuticals, Inc. (ANAC) Delisted | Executive Vice President & CFO | 104,840 | $10.19 | $1.07M | $1.67M | 20 | 2015-03-23 |
| GENOPTIX INC (GXDX) Delisted | Director | 4,167 | — | — | $0 | 4 | 2011-03-01 |
Recent Filings
126 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-15 | PRGO | Mixed | +3,798 | $41.2K | EDGAR |
| 2026-03-17 | PRGO | Grant (A) | — | $0 | EDGAR |
| 2026-02-04 | ALLO | Mixed | −24,001 | -$42.2K | EDGAR |
| 2025-12-16 | PRGO | Grant (A) | — | $0 | EDGAR |
| 2025-11-14 | PRGO | Buy (P) | +7,500 | $106.3K | EDGAR |
| 2025-10-23 | ALLO | Sell (S) | −36,744 | -$46.2K | EDGAR |
| 2025-09-16 | PRGO | Grant (A) | — | $0 | EDGAR |
| 2025-08-20 | PRGO | Buy (P) | +4,375 | $100.5K | EDGAR |
| 2025-08-19 | PRGO | Buy (P) | +4,375 | $100.5K | EDGAR |
| 2025-06-17 | PRGO | Grant (A) | — | $0 | EDGAR |